Grünenthal covers the entire value chain, from target identification, through market authorisation, manufacturing and distribution. This end-to-end approach ensures a safe, efficient and reliable product supply to patients.
Our Global Operations team aims to drive growth by ensuring excellence in their processes and by embracing digitalisation and continuously innovating how we operate. Around 2,000 people are involved in the full end-to-end value chain management of our product supply. They are committed to satisfying our customers’ demands and offering a high level of service while ensuring quality to the highest standards.
At our five specialised production sites in Chile, Ecuador, Germany, Italy and Switzerland, we manufacture our products and support our external customers. Third party manufacturing accounts for 53 percent of our overall production volume.
As a truly global partner, we know how to bring products to market at a competitive cost, with current deliveries spanning well over 100 countries worldwide. Grünenthal PRO, Grünenthal's Contract Manufacturing Business, offers a unique combination of efficient production, with high standards of quality and service level. We are able to adapt and segment our operation to different business models, from high volume generics to high complexity portfolio-driven business models, as well as continuous improvement frameworks for the competitive biopharma market.
As a well-established company, it is our long-term commitment that drives sustainable partnerships with our customers.